Early access
Sign in
WithdrawnPhase 3

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Key facts

Who runs it
Fudan University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Phase
Phase 3
Started
1 Dec 2023
Expected to end
Dec 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Cisplatin
  • Etoposide
  • radiotherapy
Record updated
27 April 2026
Why it stopped
No patients enrolled

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • 18~75 years old; Eastern Cooperative Oncology Group performance status of 0 to 2; Pathologically confirmed ; incomplete resection (R1 or R2);have adequate bone marrow, hepatic, and renal function;Patients receive incomplete resection within 3 months; Written informed consent

Who cannot take part

  • Patients with distant metastases; Patients underwent radiotherapy or chemotherapy; Patients who have malignancy history excluding carcinoma in situ of cervix in the previous five years; Active clinical pulmonary infection; Pregnant or nursing

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is designed to investigate whether adjuvant radiochemotherapy after incomplete resection has a better survival than adjuvant radiotherapy for thymoma or thymic carcinoma.

The 2 groups in the trial

  • RadiochemotherapyTreatment being tested

    adjuvant radiochemotherapy after incomplete resection: Cisplatin + Etoposide + Radiotherapy (60Gy / 30FX)

    Treatment: Cisplatin, Etoposide, and radiotherapy

  • radiotherapySham treatment, for comparison

    adjuvant radiotherapy after incomplete resection: Radiotherapy (60Gy / 30FX)

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Randomized Phase III Study of Adjuvant Radiotherapy Versus Adjuvant Radiochemotherapy in Patients With Incomplete ResectionThymoma or Thymic Carcinoma
Record updated
27 April 2026